PATENT CLAIM ANALYSIS

Application Number: 16059715
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["546", "304000"]

Abstract:
The present invention is directed to compounds of formula (I) which are inhibitors of the BACE1 enzyme. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders for which the reduction of Aβ deposits is beneficial such as Alzheimer's disease.

Claim (Index 1):
A compound of formula I wherein Ar is selected from the group consisting of phenyl, pyridyl, pyrimidyl, pyrazinyl, imidazolyl, pyrazolyl, thiazolyl, oxazolyl, isoxazolyl, and where the Ar is optionally substituted with one or more substituent selected from halogen, CN, C 1 -C 6  alkyl, C 2 -C 6  alkenyl, C 2 -C 6  alkynyl, C 1 -C 6  fluoroalkyl or C 1 -C 6  alkoxy; and R 1  is hydrogen, halogen, C 1 -C 3  fluoroalkyl or C 1 -C 3  alkyl; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 96.0
- Lexical Diversity: 1.4359
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14933301', '15524565', '15524479', '15524546', '15233463']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8587829347260879
- 35 USC 102 Novelty (BERT): 0.6153134422036646
- Combined Prediction Score: 0.8344359854738456
- Mean Citation Score: 463.81169400000016
- Max Citation Score: 552.2594
- Similarity Product: 547.7324914994716

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test